Expertise in
7
conditions

Dr. Jagoda K. Jasielec

Hematology
Office
150 Harvester Dr Ste 300, 
Burr Ridge, IL 
Accepting New Patients
14 Years of Experience
Expertise in
7
conditions
Office
150 Harvester Dr Ste 300, 
Burr Ridge, IL 

Overview

Jagoda Jasielec is a Hematologist practicing medicine in Burr Ridge, Illinois. She has been practicing medicine for over 14 years.

Dr. Jasielec is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, GTP Cyclohydrolase 1 Deficiency, Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency, Bone Marrow Transplant, and Bone Marrow Aspiration.

She is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 1 clinical trial. Dr. Jasielec is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in IL

Languages Spoken

English
Polish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO

Locations

Office
150 Harvester Dr Ste 300, Burr Ridge, IL 60527

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Drug
Study Drugs: Bortezomib, Carfilzomib, Dexamethasone, Lenalidomide
Study Phase: Phase 3

24 Total Publications

Germline predisposition in multiple myeloma.
Germline predisposition in multiple myeloma.
Journal: iScience
Published: September 08, 2024
Similar Doctors
Expertise in
25
conditions
Dr. Sonali M. Smith
Hematology | Oncology
Expertise in
25
conditions
Dr. Sonali M. Smith
Hematology | Oncology
Referral may be required

UChicago Medicine River East

355 E. Grand Ave., 
Chicago, IL 
 (19.0 miles away)
888-824-0200
Languages Spoken:
English, Greek, Gujarati , Hindi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Sonali Smith is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. Dr. Smith is highly rated in 25 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Smith is board certified in Medical Oncology and Practicing Since2001. Dr. Smith is currently accepting new patients.

Expertise in
33
conditions
Dr. Leo I. Gordon
Hematology | Oncology
Expertise in
33
conditions
Dr. Leo I. Gordon
Hematology | Oncology
Referral may be required
Before you request
675 N St Clair St Ste 21-100, Galter Pavilion, 
Chicago, IL 
 (19.4 miles away)
866-587-4322
Experience:
53+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Leo Gordon is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 53 years. Dr. Gordon is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gordon is board certified in American Board Of Internal Medicine - Hematology (Certified). Dr. Gordon is currently accepting new patients.

Expertise in
38
conditions
Dr. Rimas V. Lukas
Hematology | Oncology
Expertise in
38
conditions
Dr. Rimas V. Lukas
Hematology | Oncology
Referral may be required
Before you request

Northwestern Medicine Lou And Jean Malnati Brain Tumor Institute

675 N Saint Clair St Ste 20-100, 
Chicago, IL 
 (19.0 miles away)
Experience:
24+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rimas Lukas is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 24 years. Dr. Lukas is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioma, Glioblastoma, Brain Tumor, and Gastrostomy. Dr. Lukas is board certified in American Board Of Psychiatry And Neurology - Neurology (Certified). Dr. Lukas is currently accepting new patients.

Frequently Asked Questions about Dr. Jagoda K. Jasielec

How do I make an appointment with Dr. Jagoda K. Jasielec?

You can book an appointment with Dr. Jagoda K. Jasielec by calling their office at 773-702-1000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jagoda K. Jasielec a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jagoda K. Jasielec is classified as an Elite expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jagoda K. Jasielec specialize in?

While Dr. Jagoda K. Jasielec is a Hematology, they have specific expertise in Multiple Myeloma, GTP Cyclohydrolase 1 Deficiency, and Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Jagoda K. Jasielec participate in research or clinical trials?

Yes. Dr. Jagoda K. Jasielec has published 24 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Jagoda K. Jasielec's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jagoda K. Jasielec accept my insurance?

Dr. Jagoda K. Jasielec accepts most major insurance plans, including Humana and Oscar. We recommend calling the office directly at 773-702-1000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jasielec's expertise for a condition
ConditionClose
View All 38 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile